Agimexpharm Pharmaceutical Joint Stock Company would like to announce the adjustment of the number of registered shares at VSDC as follows:

Agimexpharm Pharmaceutical Joint Stock Company and the parties involved in the process of preparing the dossier, documents to adjust the information on the number of registered shares are fully responsible before the law for the legality, accuracy, truthfulness and completeness of the dossier; Institutions and individuals participating in the confirmation of dossier, documents shall be legally responsible within the scope related to such dossier, documents as prescribed in Clause 1, Article 11a of the Securities Law No. 54/2019/QH14 dated 26/11/2019, supplemented by Clause 4, Article 1 of Law No. 56/2024/QH15 dated 29/11/2024.